The experts group stats & facts
Experts
Countries
Publications
Recent updates
Inositols and Bone Health: Potential Therapeutic Applications in Osteoporosis Prevention and Treatment
Authors: Cipriani, F.; Gnessi, L.; Watanabe, M.; Baldelli, R.
PCOS and Inositols – Advances and Lessons We are Learning. A Narrative Review.
Authors: Lentini G, Querqui A, Monti N, Bizzarri M.
Insights from the EGOI-PCOS patient survey: Diagnosis, treatment, and quality of life according to Italian PCOS patients
Authors: Carriero VC, Forte G, Dinicola S, Oliva MM, Al Mudarris G., Unfer V.
Endocrine Metabolic Syndrome and Metabolic Syndrome: Distinct but Interrelated Pathologies
Authors: Myers SH, Soulage CO, Unfer V.
D-chiro-inositol effectively counteracts endometriosis in a mouse model
Authors: Placidi M, Casoli G, Vergara T, Bianchi A, Cocciolone D, Zaccardi S, Macchiarelli G, Palmerini MG, Tatone C, Bevilacqua A, Di Emidio G.
The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases
Authors: Quecchia C, Vianello A.
Unexpected effects of treating insulin-resistant obese women with high-dose D-chiro-inositol: opening Pandora’s box
Authors: Sabrina Basciani, Maurizio Nordio, Maria Letizia Spizzichini and Lucio Gnessi
A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”
Authors: Aragona C, Russo M, Myers SH, Espinola MSB, Bilotta G, Unfer V.
Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
Authors: Quaresima P, Myers SH, Pintaudi B, D’Anna R, Morelli M and Unfer V
Delphi consensus on the diagnostic criteria of polycystic ovary syndrome
Authors: Fabio Facchinetti, Alessandra Gambineri, Gianluca Aimaretti, Alberto Ferlin, Antonio Simone Laganà, Paolo Moghetti, Mario Montanino Oliva, Vittorio Unfer, Annamaria Colao